Cannabinoide, Cannabinoids, Κανναβινοειδή

COVID-19 | Let the experts hemp you!

 
COVID-19 is associated with multiple psychiatric problems in several groups of people, may have negative effect on patients who have psychiatric disorders predating the pandemic and is at increased risk of infection.
While the safest choice is isolation until the spread of Covid-19 stops, people’s mental health is at risk experiencing psychiatric symptoms, including depression, anxiety, insomnia, agoraphobia and distress. This psychiatric symptoms have considerably increased. During the pandemic more than 40% of the adults are reporting mental health issues.


Disclaimer: This blog is for informational and educational purposes only. We review and reference available studies and reputable sources; however, content may not reflect the most current research or regulations and should not be taken as medical, legal, or professional advice. We do not make or imply health claims. Products mentioned are not intended to diagnose, treat, cure, or prevent any disease and statements have not been evaluated by EFSA or the FDA. Effects can vary between individuals. Always consult a qualified healthcare professional before use and verify that any product or ingredient is lawful in your jurisdiction.